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Abstract
Background: Cardiovascular disease (CVD) constitutes a major public health problem in China and worldwide. We
aimed to examine classical risk factors and their magnitudes for CVD in a Chinese cohort with over 20 years follow-up.
Methods: A cohort of 5092 male steelworkers recruited from 1974 to 1980 in Beijing of China was followed up for
an average of 20.84 years. Cox proportional-hazards regression model were used to evaluate the risk of developing
a first CVD event in the study participants who were free of CVD at the baseline.
Results: The multivariable-adjusted hazard ratio (HR) associated with every 20 mmHg rise in systolic blood pressure
(SBP) was 1.63 in this Chinese male population, which was higher than in Caucasians. Compared to non-smokers,
men who smoked not less than one-pack-a-day had a HR of 2.43 (95% confidence interval [CI], 1.75-3.38). The HR
(95% CI) for every 20 mg/dl increase in total serum cholesterol (TC) and for every point rise in body mass index
(BMI) was 1.13 (1.04-1.23) and 1.06 (1.02-1.09), respectively.
Conclusions: Our study documents that hypertension, smoking, overweight and hypercholesterolemia are major
conventional risk factors of CVD in Chinese male adults. Continued strengthening programs for prevention and
intervention on these risk factors are needed to reduce the incidence of CVD in China.
Background
Cardiovascular disease (CVD) constitutes a major public
health problem in China [1] and worldwide [2]. Classical
risk factors for coronary heart disease (CHD) and stroke
have been identified [3,4], such as high blood pressure,
tobacco smoking, hypercholesterolemia, obesity and age.
The roles of major cardiovascular risk factors in the
development of CHD or stroke are well established in
Western populations. While for Chinese, data are less
extensive, especially lack of over twenty years prospec-
tive cohort study to investigate the magnitude of classi-
cal risk factors for CVD. Previous studies have proved
that the profile of CVD among Chinese is much differ-
ent from among Caucasians. Compared with Western
populations, the incidence and mortality rates of
cerebrovascular disease were much higher than those of
CHD in Chinese populations [5]. Risk factors of devel-
oping acute coronary syndrome, ischemic or hemorrha-
gic stroke were explored in a multi-provincial cohort
with 10 years follow-up [6], and results of classical risk
factors for CHD and stroke in our cohort with 13.5
years follow-up were reported previously [7,8], however,
it is unclear the profile and magnitude of classical risk
factors for CVD in a Chinese cohort with over 20 years
follow-up, and whether it was different from that in
Western populations. Therefore, we aimed to examine




A prospective cohort study of CVD has been conducted
in the Beijing Iron and Steel Complex since 1974.
Details of the study population and methods for the
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waves of recruitment (1974, 1979, and 1980), 5298 male
workers(aged 18 to 74 years) from 7 factories of the
Beijing Iron and Steel Complex attended health check,
and 5092 participants were free of CVD at the baseline.
The project health practitioners conducted follow-up
until 2001. By the year of 2001, 106 participants were
lost to follow-up and 4986 participants were included in
our cohort.
Baseline examination
In the 1974, 1979, and 1980 surveys, clinical evaluation
and laboratory measurements were performed with the
same protocol. Demographic lifestyle information and
measurements including blood pressure, total choles-
terol (TC), weight, and height were obtained. Smoking
and drinking behaviors were collected by the interview.
Blood pressure was measured in the right arm using a
standard mercury sphygmomanometer with the subject
in a sitting position. Hypertension was defined as systo-
lic blood pressure (SBP) more than or equal to 140
mmHg and/or diastolic blood pressure (DBP) more than
or equal to 90 mmHg. Pulse pressure (PP) was defined
as PP = SBP-DBP, and mean arterial pressure (MAP)
was calculated from the standard equation MAP = (2/3)
DBP+ (1/3) SBP (in mmHg). The height and weight of
each subject, wearing light clothes without shoes, were
recorded. Body mass index (BMI) was calculated as
weight (kg)/height (m)
2. TC was determined on the
same single occasion from a fasting venous blood sam-
ple, using the enzyme regent method as our previous
study reported [7]. Diabetes was not included in our
analyses because only six persons reported diabetes at
baseline.
Follow-up data collection
We carried out follow-up survey in 1982, 1987, 1993
and 2001, respectively. By the year of 2001, 2.1% of sub-
jects were lost to follow-up. The average follow-up time
was 20.84 years. If participants could not be followed up
by a way of face-to-face or telephone interview, their
relatives or colleagues were contacted for information.
Because surveillance system of CVD has been set up
since 1960s in Beijing Capital Steel and Iron Company
and most of steelworkers were treated in Capital Steel
Hospital, self-reported outcomes could be confirmed by
reviewing disease report cards and hospital records.
When participants reported CVD, their hospital records
were verified by physicians from the company hospital,
and by physicians from the cardiovascular institute and
Fu Wai hospital, Chinese Academy of Medical Sciences.
For all fatalities, death certificates were obtained to con-
firm cause of death.
This study defined CVD as a composite of CHD
events (including acute myocardial infarction [AMI],
coronary sudden death and other coronary death) and
cerebrovascular events (including ischemic stroke and
hemorrhagic stroke), but not peripheral vascular disease.
Coronary deaths included deaths caused by AMI, heart
failure and cardiac arrest.
This research was carried out in compliance with the
Helsinki Declaration. Ethics committees in Cardiovascu-
lar Institute and Fuwai Hospital, Chinese Academy of
Medical Sciences approved the study with a reference
number 110-1.
Statistical Analyses
This analysis was performed with the 4238 indivi-
duals who had no missing values for the variables
under investigation. We compared the baseline char-
acteristics of the remaining population with that of
the original population. Cox proportional-hazards
regression model was used to estimate the hazard
ratios (HRs) of CVD incidence for preventable risk
factors. Covariates included in Cox models were age,
hypertension, cigarette smoking, TC, and BMI. Parti-
cipants who had both CHD and stroke event were
censored after their first CVD event in Cox model.
Considering the problem of collinearity, blood pres-
sure indices (SBP, DBP, MAP and PP) were sepa-
rately included in the multivariate regression model
with other risk factors. The cut points of adult
underweight, overweight and obesity according to
BMI were defined by the Chinese overweight and
obesity prevention guideline [9] and the World
Health Organization (WHO) classification [10],
respectively. We also tested for interactions between
each variable and age, and compared our results with
the results of version two of the QRISK cardiovascu-
lar disease risk algorithm (QRISK2) [11].
The population-attributable risk (PAR) was also calcu-
lated to quantify the contribution of each independent
modifiable risk factor on CVD using the following equa-
tion: PAR = [P × (RR-1)]/[P × (RR-1)+1], where P sig-
nifies the prevalence of the risk factor and RR signifies
the adjusted relative risk of CVD incidence [12]. Because
the risk factor levels might change a lot during the last
two decades in China, it wasn’tv e r yc o n v i n c i b l et ou s e
the prevalence rates of these risk factors at the baseline.
Therefore we used the prevalence in our study and the
prevalence for urban male adults (18 years of age or
older) in the National Health and Nutrition Survey 2002
[13,14] to calculate the PAR. The HR from Cox regres-
sion models was used to estimate relative risk (RR). The
statistical package SPSS (version 12.0, Chicago, USA)
was used for data analysis.
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Baseline Characteristics of the Study Population
The baseline characteristics of the original population
and the remaining population in this analysis are pre-
sented in Table 1. The remaining population was repre-
sentative of the original population. During the follow-
up, 391 subjects developed a first CVD event in the
remaining population, including 255 cases of stroke and
136 cases of CHD events. A total of 599 deaths were
reported, 240 persons died of CVD, 194 persons died of
neoplasm and 165 persons died of other disease and
injury.
Multivariate analyses of classical risk factors
Table 2 shows the results of the Cox regression analyses
for the final model. There were continuous, graded
increases in CVD risk either for every 20 mmHg rise of
SBP, or for every 10 mmHg rise of DBP. For the men
with the highest level of blood pressure(SBP ≥ 180
mmHg or DBP ≥ 100 mmHg) had the highest risk of
CVD, and the HRs (95% confidence interval [CI]) was
7.56(4.71-12.14) and 4.19(3.07-5.71), respectively. Com-
pared to non-smokers, the multivariable adjusted HR of
CVD was 2.43 (95% CI, 1.75-3.38) for men who smoke
more than or equal to one-pack-a-day. In multivariate
analysis, there was an increased risk of CVD only in the
group of TC category greater than or equal to 220 mg/
dL, with a HR of 1.42(95%CI, 1.08-1.85).
Table 3 shows the results about BMI according to the
WHO classification and the Chinese classification for
underweight, normal weight, overweight and obesity.
The average BMI in this study sample was 23.2 kg/m
2;
35.0% of participants were overweight (BMI ≥ 24 kg/
m
2), and 5.2% were obesity (BMI ≥ 28 kg/m
2). The HR
for overweight and obesity was 1.24 (95% CI, 1.01-1.52)
and 1.37 (95% CI, 0.96-1.97), respectively. When treated
as a continuous variable, the HR for CVD was 1.16(95%
CI, 0.99-1.37) for 5 points rise of BMI (Table 4).
Table 4 also shows the comparison between the
results of Chinese steelworkers cohort and the results of
males from the derivation cohort of QRISK2 model.
The most difference was that the HR of CVD associated
with every 20 mmHg rise in systolic blood pressure
(SBP) in our study was much higher than result of
QRISK2 model(1.63 vs. 1.19).
The PAR of hypertension, smoking, overweight (BMI
≥ 24 kg/m
2) and hypercholesterolemia (> 220 mg/dl or
5.7 mmol/l) was 29.2%, 29.4%, 7.7% and 4.8%, respec-
tively for CVD when using the risk factors prevalence of
our study. While using the prevalence rates of risk fac-
tors in urban men in the National Health and Nutrition
Survey 2002, the PAR for hypertension, smoking, over-
weight and hypercholesterolemia was 20.8%, 22.7%, 6.9%
and 1.1%, respectively.
Discussion
Since the Framingham heart study examined major risks
of CVD in white American[15], a few studies at the
population level in exploring different patterns of CVD
risks between Chinese population and Caucasians have
been reported[7,8,16,17], and risk scores for local popu-
lation other than the Framingham score have subse-
quently been published[18,19]. Liu, et al [17]
recalibrated the Framingham functions by using the
mean values of risk factors and mean CHD incidence
rate from Chinese Multi-Provincial Cohort Study
(CMCS), given a much lower CHD incidence rate in
China compared with that in Framingham, the United
States. Our previous reports [7,8] also indicated that
stroke was more prevalent than CHD in China by a
cohort with an average 13.5 years follow-up. Further-
more, application of recalibrated Framingham models
for ischemic cardiovascular disease (including ischemic
stroke and coronary events) significantly overestimated
the CHD risk in another Chinese cardiovascular epide-
miology cohort [16]. It is controversial whether a recali-
brated Western risk function can be useful in China.
Except that risk prediction using CMCS and PRC-USA
risk coefficients differed from Framingham, there were
differences between the two Chinese cohort studies as
Table 1 Baseline characteristics of the Beijing steel workers cohort
Variables Entire cohort (N = 4986) means ± SD Cohort used in this study (N = 4238) means ± SD
Age (yr) 4975 45.08 ± 7.82 4238 44.91 ± 7.93
TC (mg/dl) 4521 186.25 ± 38.65 4238 187.58 ± 37.87
BMI (kg/m
2) 4782 23.18 ± 2.72 4238 23.17 ± 2.71
SBP (mmHg) 4976 123.26 ± 18.86 4238 122.89 ± 18.67
DBP (mmHg) 4976 80.91 ± 11.89 4238 80.80 ± 11.83
PP (mmHg) 4976 42.34 ± 11.78 4238 42.09 ± 11.77
MAP (mmHg) 4976 95.03 ± 13.49 4238 94.83 ± 13.37
Hypertension (%) 4976 32.13 4238 31.69
Cigarette smoker (%) 4932 73.44 4238 73.36
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Variables Range CVD events Number Person-years Incidence (per
1000 person years)
HR 95%CI
SBP (mmHg) < 120 88 1712 35895 2.45 1 -
120-139 136 1641 33646 4.04 1.52 1.16-1.99
140-159 99 635 12451 7.95 2.48 1.84-3.36
160-179 45 194 3465 12.99 3.59 2.47-5.24
≥ 180 23 56 831 27.68 7.56 4.71-12.14
DBP (mmHg) < 80 75 1529 31955 2.35 1 -
80-89 111 1500 30971 3.58 1.49 1.11-2.00
90-99 96 751 15015 6.39 2.27 1.67-3.10
≥ 100 109 458 8347 13.06 4.19 3.07-5.71
PP (mmHg) < 35 72 1099 23008 3.13 1 -
35-44 136 1737 35663 3.81 1.15 0.87-1.54
45-54 93 909 18289 5.09 1.41 1.03-1.93
≥ 55 90 493 9328 9.65 2.08 1.50-2.87
MAP (mmHg) < 83.34 50 1112 23095 2.16 1 -
83.34-93.33 85 1335 27824 3.05 1.32 0.93-1.88
93.34-103.33 85 918 18885 4.5 1.75 1.23-2.50
≥ 103.34 171 873 16484 10.37 3.49 2.51-4.86
Cigarette dosage (cigarettes/day) Non-smoker 85 1126 23280 3.65 1 -
1-9 89 1054 21334 4.17 1.37 1.02-1.85
10-19 153 1691 33991 4.5 1.47 1.12-1.92
≥ 20 64 367 7683 8.33 2.43 1.75-3.38
TC (mg/dl) < 180 128 1879 38362 3.34 1 -
180-199.9 90 931 18968 4.74 1.14 0.87-1.50
200-219.9 77 682 13889 5.54 1.25 0.94-1.66
≥ 220 96 746 15069 6.37 1.42 1.08-1.85
BMI (kg/m
2) - 391 4238 1.06 1.02-1.09
Adjusted for age, TC, BMI, SBP, and daily cigarette dosage.
Table 3 Two types of classification of adult underweight, overweight and obesity
BMI (kg/m
2) CVD events Number Person years Incidence (per
1000 person years)
HR 95%CI P value
The WHO classification †
Underweight < 18.5 5 99 1999 2.5 0.7 0.29-1.69 0.43
Normal range 18.5-24.9 254 3151 64748 3.92 1 -
Overweight ≥ 25.0 132 988 19541 6.76 1.25 1.00-1.55 < 0.05
Pre-obesity 25.0-29.9 120 929 18450 6.5 1.22 0.97-1.52 0.09
Obesity ≥ 30.0 12 59 1091 11 1.72 0.96-3.08 0.07
The Chinese Classification ‡
Underweight < 18.5 5 99 1999 2.5 0.72 0.29-1.74 0.46
Normal range 18.5-23.9 204 2655 54726 3.73 1 -
Overweight ≥ 24.0 182 1484 56725 3.21 1.24 1.01-1.52 < 0.05
Pre-obesity 24.0-27.9 145 1265 25398 5.71 1.21 0.97-1.50 0.09
Obesity ≥ 28.0 37 219 4165 8.88 1.37 0.96-1.97 0.09
Adjusted for age, TC, BMI, SBP, and daily cigarette dosage.
† According to World Health Organization’ web http://apps.who.int/bmi/index.jsp?introPage=intro_3.html
‡ According to Chinese overweight and obesity prevention guideline
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ing CVD in Chinese adults are not established. There-
fore this study adds important information regarding
the epidemiology of CVD and its risk factors in China.
Furthermore, to our knowledge, this cohort followed up
for an average of 20.84 years is the longest Chinese
cohort specified for CVD events.
Prevalences of hypertension, hypercholesterolemia,
and obesity in our cohort were lower than that in Cau-
casian cohorts, such as the MONICA cohort in Augs-
burg, Germany, but the prevalence of hypertension was
still higher than that in China National Nutrition and
Health Survey 2002 (32% vs. 20%). Smoking was much
more prevalent in our cohort. The smoking rate in our
cohort (73.4%) was similar with that of urban men from
the PRC-USA cooperative study (71%-78%) [20], but
higher than that for male adults who were 40 years of
age or older in China National Hypertension Survey
1991(59.1%) [21].
In this study, we focused on magnitude of classical
risk factors for CVD. We also compared our results
with the HRs of QRISK2 model in derivation cohort
(Table 4). QRISK2 was a prospective cohort study con-
ducted in a large UK primary care population (2.3 mil-
lion people aged 35-74 with 140 000 cardiovascular
events) [11]. Although the QRISK2 model was derived
mostly from European, there were still 22,013 south
Asian and 19,792 from Chinese or other Asian or other
ethnic groups among the overall population. Meanwhile,
the characteristics of Chinese-English in derivation
cohort of QRISK2 were similar with our baseline char-
acteristics, for example, SBP (125.0 vs. 122.9 mmHg),
BMI (23.4 vs. 23.2 kg/m
2)a n da g ea te n t r y( 4 9 . 0v s .
44.9). Therefore, we compared the magnitude of classi-
cal risk factors in these two studies.
Blood Pressure
The HR (1.30, 95% CI: 1.23-1.37) of CVD events for 10
mmHg rise in SBP in our cohort was higher than that
(1.19, 95% CI: 1.17-1.20) in Caucasian study [11]. Our
study indicated raised blood pressure is the leading pre-
ventable risk factor for CVD in the Chinese general
population. There was a continuous graded increase in
risk of CVD as blood pressure increased, with no evi-
d e n c eo fat h r e s h o l dv a l u e .T h i si sc o n s i s t e n tw i t ht h e
findings in the studies of Chinese and Asian population
[17,22,23]. In QRISK2, there was an interaction between
SBP and age on CVD. However, the interaction between
SBP and age on CVD did not reach statistical signifi-
cance in our study.
We also reported HRs of DBP, MAP and PP for every
10 mmHg rise in the prediction of CVD. These four BP
indices represent different clinical meanings. The Physi-
cians’ Health Study suggested that SBP, DBP, and MAP
strongly predict CVD among men younger than 60
years[24], whereas most studies showed that PP is a
more useful and independent predictor for the risk of
CVD in older people[25-28].
Smoking
Cigarette smoking is another important risk factor of
CVD for men in China because of its high prevalence. A
nationally representative sample of Chinese adult cohort
has reported RR of CVD for male cigarette smoker [29].
Though adjusted HRs for smoking in men of the Fra-
mingham Heart Study and the QRISK2 model were
higher than that in our cohort (1.92 and 1.65 vs. 1.54)
[11,30], our result was similar to that of Chinese
national hypertension surveys [29].
The dose-response relationship between tobacco
smoking and HR of CVD was observed in our study
(Table 2). The effect of cigarette smoking on cardiovas-
cular health is evident even at the lowest levels of expo-
sure in Western study [31]. Similarly, the HR was
statistically significant in the lowest cigarette dosage
group (1-9 cigarettes/day) in our cohort. Moreover, an
interaction between age and smoking on CVD was iden-
tified in our study (Table 4), which was different from
Table 4 Multivariable adjusted hazard ratios (95% CI) for CVD from selected studies for men
Characteristics Chinese steelworkers cohort derivation cohort of QRISK2 model
HR 95% CI HR 95% CI
Age (5 years increase) 1.29 1.18-1.40 1.59 1.58-1.60
SBP (20 mmHg increase) 1.63 1.48-1.80 1.19 1.17-1.20
Current smoker 1.54 1.21-1.97 1.65 1.60-1.70
TC 1.13 † 1.04-1.23 1.19 ‡ 1.18-1.20
BMI (5 kg/m
2 increase) 1.16 0.99-1.37 1.09 1.07-1.11
Age* SBP interaction 0.993 0.920-1.070 0.964 0.960-0.969
Age* smoking interaction 1.211 1.010-1.451 0.932 0.922-0.942
Age* BMI interaction 0.955 0.929-0.981 0.985 0.979-0.991
Adjusted for age, TC, BMI, SBP, and Current smoker. † TC for 20 mg/dL increase, ‡ For Cholesterol/HDL ratio
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indicated that Chinese male smokers would have extra
risk of CVD with the increase of age, and also impli-
cated that smoking cessation may provide more benefits
for CVD prevention in China.
Total Cholesterol
A report indicated that 23.8% and 9.0% of the Chinese
adult population have a total cholesterol level between
200 mg/dL and 239 mg/dL and ≥ 240 mg/dL, respec-
tively [32], which was similar with our results (24.7%
and 9.0%). The multivariable adjusted HR of TC in our
study was similar to that of Caucasians. However the
baseline level of TC in our study was much lower than
that in the Framingham study and QRISK study, the
role of hypercholesterolemia for CVD in Chinese was
not as high as in Caucasians.
With decreasing cholesterol levels, previous study
reported a trend towards an increase in risk of hemor-
rhagic stroke [23]. Although 21.8% of the participants
with the serum TC level below 160 mg/dl, no such
trend was detected in our current study (data not
shown). Our result was consistent with the Heart Pro-
tection Study [33].
Body Mass Index
Although overweight and obesity were not included in
the general CVD risk prediction model of the Framing-
ham Heart Study [30], the impact of body mass index
on the risk of CVD incidence was proven by many stu-
dies. European guidelines on cardiovascular disease pre-
vention suggested that avoiding overweight or reducing
existing overweight should be important in patients with
established CVD as well as in high risk people [34]. BMI
was used as a predictive parameter for CVD in QRISK
and QRISK2 models. The magnitude of BMI for CVD
in our cohort was even greater than that in QRISK2. In
QRISK2, there was a negative interaction between BMI
and age on risk of CVD (0.985, 95% CI: 0.979-0.991),
similar finding was found in our population (Table 4).
Participants of our study had a lower average BMI than
those of most Caucasians studies [4,11,19,35]. For exam-
ple, the average BMI in our study was 3.1 kg/m
2 lower
than that of males in Framingham Heart Study. While
there were positive associations between overweight and
CVD either according to WHO definition or according
to Chinese definition. However, using WHO classifica-
tion might underestimate the number of obesity in Chi-
nese population. In fact, there were only 59 participants
(1.4%) with BMI ≥ 30 kg/m
2 in our cohort. Using 24 kg/
m
2 and 28 kg/m
2 as the cut points for overweight and
obesity in Chinese adults was recommended by the Chi-
nese overweight and obesity prevention guideline, and
was applied in many previous studies [36-38].
Overall, the role of overweight for CVD was con-
firmed in our study, and body weight controlling would
reduce the incidence of CVD in Chinese males.
Generally speaking, using prevalence rates of these
risk factors 20 year ago to estimate PARs of risk factors
might be influenced by the changing of prevalence rates
in this population. However, the PAR estimates using
the risk factor levels of urban men in the National
Health and Nutrition Survey 2002 were lower than
expected. Compared with our results, the most differ-
ence was the PAR for hypercholesterolemia. Because the
prevalence rate of hypercholesterolemia was only 3.7%
in that national survey, it would obviously underestimate
individual’s number in our study (17.6%) if using the
prevalence of the survey 2002. Other risk factors preva-
lence was also higher than that in national survey 2002
(hypertension, 31.7% vs. 20.2%, smoking 73.4% vs.
51.7%, overweight 35.0% vs. 31.1%). Considering the
higher living standard in Beijing, it is reasonable that
the prevalence of CVD risk factors in our cohort
advanced the average levels in China. Therefore, the
PARs derived from our study have much more practical
significance.
Limitations
Some limitations of our study should be noted.
Although prospective and with a long follow-up time,
the Beijing Iron and Steel cohort study is workplace
based and therefore not necessarily representative of the
general population. After the 1978 economic reforms,
China has experienced very rapid economic growth. The
consequent improvement in living conditions, nutrition,
and health care in the past several decades would affect
risk factor levels and result in epidemiologic transition
of diseases pattern. Though we have used the risk factor
levels of urban men in the National Health and Nutri-
tion Survey 2002 to calculate the PARs, it should be
caution when applied those results into the general
population. In addition, our cohort was restricted with
very limited number of diabetes, and total cholesterol
alone was measured because high density lipoprotein
(HDL) cholesterol test was not widely used in China
during the 1980s. Thus, the impacts of diabetes and
HDL cholesterol on cardiovascular disease risk could
not be assessed.
Conclusions
Our prospective data demonstrates that hypertension,
cigarette smoking, overweight, hypercholesterolemia, are
major risk factors for CVD. Hypertension and Cigarette
smoking are the leading predictive parameter for CVD
in Chinese male adults, and the association between
blood pressure and CVD in Chinese is stronger than in
Caucasians. To reduce incidence of CVD in Chinese
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tion and intervention on these risks is needed.
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